I know that diabetes can take a real toll on your body, but I didn't know that it includes your eyes. How are they affected ...

Kamuvudines are a new class of drugs that are derived from the anti-HIV nucleoside reverse transcriptase inhibitors. They are designed to inhibit the inflammasome, part of the innate immune system ...

Diabetic retinopathy (DR) is a leading cause of blindness among working-age adults, affecting more than 130 million people ...

Optogenetics offers mutation-independent vision restoration for IRDs, with promising early-phase results in retinitis ...

Background/Aims Diabetic retinopathy (DR) is a major ocular complication of diabetes mellitus. While artificial intelligence ...

From tackling the global challenge of diabetic retinopathy to interactive art exhibits in Atlanta, Kennesaw State ...

This article is part of “Innovations In: Type 1 Diabetes”, an editorially independent special report that was produced with financial support from Vertex. Sterling Glass had many health problems as a ...

Hypoglycemia is linked to an increased risk for and progression of diabetic retinopathy, according to new research presented at The Retina Society (TRS) Annual Meeting 2025. Severe hypoglycemia is ...

Please provide your email address to receive an email when new articles are posted on . LAS VEGAS — In this Healio Video Perspective, Dante J. Pieramici, MD, discusses a trial investigating contrast ...

GLP-1 receptor agonists linked to modestly increased risk for incident DR, but tied to reduced risk for certain complications of DR. (HealthDay News) — For individuals with type 2 diabetes (T2D), ...

A retrospective cohort study suggested that users of GLP-1 receptor agonists had a 7% higher incidence of new-onset diabetic retinopathy. In patients with existing diabetic retinopathy, use of GLP-1 ...

LONG BEACH, Calif. -- Two different ocular implants eluting an endothelin antagonist showed early promise for slowing diabetic eye disease, according to two small studies reported here. In a ...